Search
recombinant antithrombin (ATryn)
Indications:
- hereditary antithrombin deficiency
- *prevention of peri-operative & peri-partum thromboembolism
- *treatment of established DVT
Contraindications:
- not indicated for treatment of thromboembolic events in the absence of hereditary antithrombin deficiency
Mechanism of action:
- recombinant antithrombin
Interactions
drug adverse effects of antithrombotic agent(s)
Specific
recombinant antithrombin-III
General
recombinant protein; chimer
antithrombin
References
- Prescriber's Letter 17(2): 2010
New Drugs Approved by the FDA in 2009
Detail-Document#: 260213
(subscription needed) http://www.prescribersletter.com
- Medical Knowledge Self Assessment Program (MKSAP) 17,
American College of Physicians, Philadelphia 2015